Literature DB >> 14441309

General and pulmonary hemodynamic effects of pure decapeptide angiotensin in normotensive man.

S M SANCETTA.   

Abstract

Entities:  

Keywords:  BLOOD PRESSURE/pharmacology; HYPERTENSIN/pharmacology; PULMONARY ARTERY/pharmacology

Mesh:

Substances:

Year:  1960        PMID: 14441309     DOI: 10.1161/01.res.8.3.616

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

1.  A comparison of the circulatory effects of angiotensin, vasopressin and adrenaline in the anaesthetized cat.

Authors:  G R BARER
Journal:  J Physiol       Date:  1961-04       Impact factor: 5.182

2.  STUDIES ON THE RELATIVE CARDIAC AND PERIPHERAL ACTIONS OF ANGIOTENSIN.

Authors:  W B BERRY; W G AUSTEN; W D CLARK
Journal:  Ann Surg       Date:  1964-04       Impact factor: 12.969

3.  STUDIES IN CLINICAL SHOCK AND HYPOTENSION. II. HEMODYNAMIC EFFECTS OF NOREPINEPHRINE AND ANGIOTENSIN.

Authors:  J N COHN; M H LURIA
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

4.  The response of normal retinal blood vessels to angiotensin and noradrenaline.

Authors:  C T DOLLERY; D W HILL; J V HODGE
Journal:  J Physiol       Date:  1963-03       Impact factor: 5.182

5.  [Angiotensin].

Authors:  F GROSS
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1963

6.  Angiotensin-a new pressor agent.

Authors:  J R DERRICK; B ROLAND; J ANDERSON
Journal:  Ann Surg       Date:  1962-08       Impact factor: 12.969

Review 7.  Pressor agents.

Authors:  N T Smith
Journal:  Calif Med       Date:  1967-07

8.  Acute hemodynamic effects of angiotensin II. Preliminary report.

Authors:  G R CUMMING
Journal:  Can Med Assoc J       Date:  1963-04-20       Impact factor: 8.262

9.  Peripheral vascular resistance and angiotensin II levels during pulsatile and non-pulsatile cardiopulmonary bypass.

Authors:  K M Taylor; W H Bain; M Russell; J J Brannan; I J Morton
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.